Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

China Pharma Holdings (CPHI) Other Gross PP&E Adjustments (2016 - 2025)

China Pharma Holdings' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at $34.3 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 6.88% year-over-year to $34.3 million; the TTM value through Dec 2025 reached $34.3 million, down 6.88%, while the annual FY2025 figure was $34.3 million, 6.88% down from the prior year.
  • Other Gross PP&E Adjustments reached $34.3 million in Q4 2025 per CPHI's latest filing, down from $37.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $37.9 million in Q3 2024 to a low of -$25369.0 in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $20.1 million, with a median of $31.4 million recorded in 2022.
  • Peak YoY movement for Other Gross PP&E Adjustments: crashed 105.37% in 2021, then surged 6978.34% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $488309.0 in 2021, then soared by 5733.46% to $28.5 million in 2022, then surged by 31.21% to $37.4 million in 2023, then dropped by 1.31% to $36.9 million in 2024, then fell by 6.88% to $34.3 million in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Other Gross PP&E Adjustments are $34.3 million (Q4 2025), $37.3 million (Q3 2025), and $37.2 million (Q2 2025).